Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

VIOGEUR

(VIOGEUR)

Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
07/08/20242:48AMAlliance NewsAlliance NewsLONDON BRIEFING: Carlsberg to buy Britvic in GBP3.3 billion deal
07/08/20242:37AMGlobeNewswire Inc.Share repurchase programmeTG:JYS1Jyske Bank AS
07/08/20242:30AMGlobeNewswire Inc.VIRBAC: exceptional first-half growth and guidance raised for 2024EU:VIRPVirbac SA
07/08/20242:30AMGlobeNewswire Inc.VIRBAC announces executive management changesEU:VIRPVirbac SA
07/08/20242:30AMGlobeNewswire Inc.Virbac annonce des changements au sein de sa direction généraleEU:VIRPVirbac SA
07/08/20242:30AMGlobeNewswire Inc.VIRBAC: croissance exceptionnelle sur le premier semestre et relèvement de la guidance pour l’année 2024EU:VIRPVirbac SA
07/08/20242:30AMPR Newswire (US)K1 Speed's Global Expansion Races Into Italy With Hollywood Kart Partnership
07/08/20242:30AMPR Newswire (US)Novo Holdings co-leads £90 million ($114 million) Series A financing for Myricx Bio to advance a novel payload class for antibody-drug conjugates
07/08/20242:30AMPR Newswire (US)K1 Speed's Global Expansion Races Into Italy With Hollywood Kart Partnership
07/08/20242:30AMPR Newswire (US)Novo Holdings co-leads £90 million ($114 million) Series A financing for Myricx Bio to advance a novel payload class for antibody-drug conjugates
07/08/20242:22AMBusiness WireInstitut für Pathologie der Technischen Universität München erzielt hervorragende Ergebnisse beim QuIP Proficiency-Test zur Erkennung von ESR1-Mutationen mit einem Hedera Dx Liquid Biopsy Testpanel
07/08/20242:19AMPR Newswire (US)Sirnaomics Announces Interim Results for Successful Completion of the Second Cohort of Phase I Clinical Study of GalNAc-Based RNAi Therapeutic STP122G for Anticoagulant Therapeutics
07/08/20242:16AMAlliance NewsAlliance NewsIrish construction activity decline accelerates in June - PMI
07/08/20242:14AMGlobeNewswire Inc.Preliminary data on early redemptions (prepayments)
07/08/20242:12AMAlliance NewsAlliance NewsTOP NEWS: German trade surplus grows as exports and imports both slip
07/08/20242:10AMGlobeNewswire Inc.Mujtaba Khalid, Islamic finance thought leader, joins XTCC Advisory Team
07/08/20242:07AMGlobeNewswire Inc.OKX Wallet Now Integrated with The Beacon, an Action RPG
07/08/20242:00AMGlobeNewswire Inc.LEXIBOOK : RÉSULTATS ANNUELS 2023-24 CONFORMES AUX ATTENTES : CHIFFRE D’AFFAIRES ANNUEL À 58,6M€ (+14,4%). REX ET RN EN CROISSANCE RESPECTIVEMENT À +6,0M€ ET À +5,0M€ GRACE A UNE CONJONCTION EXCEPTIONNELLE DE FACTEURS POSITIFS.EU:ALLEXLexibook Linguistic Electronic System SA
07/08/20242:00AMGlobeNewswire Inc.Memo Therapeutics AG appoints Paul Carter as Chairperson
07/08/20242:00AMGlobeNewswire Inc.Myricx Bio Announces £90m ($114m) Series A Financing to Advance its Novel NMTi-ADC Therapeutics into Clinical DevelopmentNYSE:ADCTADC Therapeutics SA
07/08/20242:00AMBusiness WireSignum Surgical Granted FDA De Novo Clearance for BioHealx™
07/08/20242:00AMBusiness WireEpsilogen announces CTA approval for Phase Ib trial of MOv18 IgE in platinum-resistant ovarian cancer
07/08/20242:00AMGlobeNewswire Inc.Renforcement en Europe
07/08/20242:00AMGlobeNewswire Inc.Myricx Bio Announces £90m ($114m) Series A Financing to Advance its Novel NMTi-ADC Therapeutics into Clinical DevelopmentNASDAQ:CGCarlyle Group Inc
07/08/20242:00AMGlobeNewswire Inc.Volta Finance Limited - Dividend DeclarationLSE:VTAVolta Finance Limited
07/08/20242:00AMGlobeNewswire Inc.EUR 200 million share buyback program beginsLSE:31QWAegon Nv
07/08/20242:00AMGlobeNewswire Inc.EUR 200 million share buyback program beginsLSE:AGNAegon Nv
07/08/20242:00AMGlobeNewswire Inc.EUR 200 million share buyback program beginsTG:AENDRegistered Shares
07/08/20242:00AMGlobeNewswire Inc.Evolution de la Gouvernance de la sociétéEU:OREGEOrege
07/08/20242:00AMGlobeNewswire Inc.EUR 200 million share buyback program beginsBIT:AGNAegon N V